Delivery Order SPE2DB22D3401-SPE2DB24FT3WT

Award Date 7/19/24
Potential Completion Date 8/9/24
Potential Value $5.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $10,947.00, is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical supplies. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,298 firm fixed-price delivery order is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product, with a period of performance through March 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,170.72, is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product, with a period of performance through November 15, 2024. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,473.50 fixed-price delivery order contract is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product, with a period of performance through April 15, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award is a delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of 4565453619 GEL-ONE 30 MG/3 ML SYRINGE 3ML. The contract has a ceiling value of $5,290.80, a firm fixed price, and was awarded on July 31, 2024 with an ultimate completion date of August 21, 2024. The contracting agency is the Defense Logistics Agency (DLA), a defense agency. This delivery order is part of a larger Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $5,838.40. The award is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product, with a performance period through July 7, 2025. This contract is not a set-aside award. AmerisourceBergen Drug Corp holds a significant Indefinite...
The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical products. The contract, awarded by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price of $5,473.50 and a completion date of January 3, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical supplies, with a ceiling value of $3,649.00. The contract is a firm fixed price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $1,824.50. The contract is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product, with a period of performance through July 2, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp...
The U.S. Defense Logistics Agency (DLA) awarded a $10,581.60 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide GEL-ONE 30 MG/3 ML SYRINGE 3ML. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB24FT3WT
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp is for a delivery order valued at $5,290.80 for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of August 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 10/18/24, 9:26 AM